(Press-News.org) HOUSTON – (Aug. 26, 2014) – Binge eating, an eating disorder in which a person frequently consumes unusually large amounts of food in a short period of time, affects about 5 to 10 percent of U.S. adults and is more common in women than men. Researchers at the USDA/ARS Children's Nutrition Research Center at Baylor College of Medicine and Texas Children's Hospital found that the hormone estrogen can specifically trigger brain serotonin neurons to inhibit binge eating in female mice in a report today in the Journal of Clinical Investigation.
"Previous data has shown that women who have irregular menstrual cycles tend to be more likely to binge eat, suggesting that hormones in women play a significant role in the development or prevention of the behavior," said Dr. Yong Xu, assistant professor of pediatrics and senior author of the paper. "Previous data has also shown that in humans, there is a strong association between estrogen and binge eating. When estrogen is high, binge eating is inhibited, but when estrogen is low, binge eating becomes more frequent. Using mouse models, we set out to see what the effects of estrogen were on binge behavior in female mice."
In this study, Xu and colleagues first found that estrogen can strongly inhibit binge eating in mice, which was consistent with data in humans.
"We can speculate that in women who develop binge eating who also happen to have irregular menstrual cycles, it is probably because their estrogen function is somehow damaged, which is what leads to the development of binge eating," said Xu.
Xu and colleagues went further to determine what receptor was mediating the estrogen effect on binge eating and where this receptor was located. Using genetic mouse models, they found that the estrogen receptor-α, expressed by serotonin neurons in the brain, mediates the effect of estrogen to suppress binge eating.
"The significance is not only understanding the mechanism of how estrogen may modulate this behavior, but from a more therapeutic point of view, this would identify a potential target for estrogen therapy or modified estrogen therapy for treatment of this problem," said Xu.
However, Xu notes that the current estrogen therapy in practice has been a problem because it produces detrimental effects, such as high risk of breast cancer.
"We thought, if we can understand where and how the estrogen acts to produce some benefits, maybe that will facilitate the development of an estrogen-based therapy that could be more specific and would just produce the benefits and bypass the side effects, such as breast cancer," he said.
Around this same time, Xu's collaborators at Indiana University developed a compound called GLP-1-estrogen, which was a conjugate between the peptide GLP-1 and estrogen. The idea was that GLP-1 would be used to carry the estrogen and deliver it to a region where there are GLP-1 receptors as well as estrogen receptors and the estrogen would be released there, producing a biological function. His collaborators at Indiana University published that this compound was good for body weight control and would not increase the risk of breast cancer because the compound did not deliver estrogen to the breast tissue.
Xu and colleagues used this compound to show that when a systemic injection of this compound is given in mice, there is increased activity of estrogen in the serotonin region of the brain, meaning the compound can deliver estrogen in the serotonin region where they believed binge behavior is regulated.
They further showed that the compound actually substantially inhibits binge eating in mice, and their data showed that part of this effect comes from the estrogen and the other part of the effect comes from the GLP-1.
"There are a few studies showing that binge patients tend to have decreased GLP-1 in their blood, but nobody had shown that GLP-1 suppresses binge eating in animals or humans until now," said Xu. "We showed that these two things, estrogen and GLP-1, work together to decrease binge eating and that GLP-1 can carry estrogen to this specific site to produce a benefit, but bypasses the breast tissue."
Xu notes that this provides a strong case for an interventional drug that specifically acts on estrogen receptor-α in the serotonin region of the brain to treat binge eating.
The next steps in Xu's research will be to determine the mechanism by which estrogen regulates serotonin neurons. He and colleagues also hope to go downstream of serotonin to see if increasing serotonin release inhibits binge eating.
INFORMATION:
Others who took part in this study include Pingwen Xu, Mario G. Oyola, Yan Xia, Xiaofeng Yan, Kenji Saito, Fang Zou, Chunmei Wang, Yongjie Yang, Antentor Hinton Jr., Chunling Yan, Hongfang Ding, Likai Yu and Shaila K. Mani of Baylor; Xuehong Cao of Baylor and Wuhan Polytechnic University in China; Liangru Zhu of Baylor and Huazhong University of Sciences & Technology in China; Bin Yang and Richard DiMarchi of Indiana University; Yuxin Feng and Sohaib Khan from the University of Cincinnati College of Medicine; Deborah J. Clegg of the University of Texas Southwestern Medical Center; and Qingchun Tong of the University of Texas Health Science Center at Houston.
Funding for this study came from grants from the National Institutes of Health (R01DK093587, R00DK085330, P30 DK079638-03, T32CA059268, HD62512 and R01DK092605), the National Science Foundation (IOS1424017), the American Diabetes Association, Marcadia Biotech, the Klarman Family Foundation, the Naman Family Fund for Basic Research, the Curtis Hankamer Basic Research Fund and the American Heart Association.
New estrogen-based compound suppresses binge-like eating behavior in female mice
2014-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Researchers discover fever's origin
2014-08-27
Fever is a response to inflammation, and is triggered by an onset of the signaling substance prostaglandin. Researchers at Linköping University in Sweden can now see precisely where these substances are produced – a discovery that paves the way for smarter drugs.
When you take an aspirin, all production of prostaglandins in the body is suppressed. All symptoms of inflammation are eased simultaneously, including fever, pain and loss of appetite. But it might not always be desirable to get rid of all symptoms – there is a reason why they appear.
"Perhaps you want to inhibit ...
Tumor blood vessel protein provides potential therapeutic target
2014-08-27
Tumor blood vessels supply oxygen and nutrients to cancer cells and provide access to other organs. While tumor vasculature shares many features with normal vessels, their unique characteristics are potential therapeutic targets. A recent study in the Journal of Clinical Investigation identifies a tumor vessel-specific protein, L1 that can be targeted to reduce tumor growth. Using a mouse pancreatic cancer model, Ugo Cavallaro and colleagues at the European Institute of Oncology found that loss of L1 reduced tumor blood vessel formation, which inhibited growth and metastasis. ...
Targeting estrogen receptors prevents binge eating in mice
2014-08-27
Binge easting disorder affects approximately 5% of adults in the US. Left unchecked, this disorder leads to health complications, including obesity, hypertension, and diabetes. The cause of this disease is poorly understood and treatment options are limited. A new study in the Journal of Clinical Investigation suggests that estrogen replacement may limit binge-eating behaviors. Using a mouse binge-eating model, Yong Xu and colleagues at Baylor School of Medicine found that estradiol suppressed binge eating behaviors. This effect required the presence of estrogen receptors ...
Young children's sipping/tasting of alcohol reflects parental modeling
2014-08-26
A new study examines antecedent predictors of childhood initiation of sipping or tasting alcohol.
Findings indicate that initiation of sipping/tasting was less related to psychosocial proneness for problem behavior and more related to perceived parental approval for child sipping.
Previous research had determined that whether or not a child sips or tastes alcohol is associated with the child's attitude toward sipping and with a family environment supportive of alcohol use. This study extends this former research to examine antecedent predictors of childhood initiation ...
Prenatal alcohol exposure is associated with later excess weight/obesity during adolescence
2014-08-26
Growth deficiency is a defining feature of Fetal Alcohol Spectrum Disorders (FASD).
A new study has found that rates of excess weight/obesity are elevated in adolescents with partial fetal alcohol syndrome (pFAS).
Females with FASD may be at a greater risk for excess weight/obesity than males during adolescence.
Fetal Alcohol Spectrum Disorders (FASD) refer to a range of disabilities, and include individuals with neurocognitive impairments as well as growth irregularities ranging from deficient to normal. However, very little is known about the prevalence of excessive ...
Alcoholics have an abnormal CD8 T cell response to the influenza virus
2014-08-26
Chronic drinking is associated with an increased incidence and severity of respiratory infections.
A reduced CD8 T cell response was previously implicated in increased disease severity due to influenza virus infections.
New rodent findings indicate that only some CD8 T cell functions are damaged while others remain intact.
It is well known that chronic drinking is associated with an increased incidence and severity of respiratory infections. Previous research had demonstrated that an increase in disease severity to influenza virus (IAV) infections was due, in part, ...
Hypertension self-management program helps reduce blood pressure for high-risk patients
2014-08-26
Among patients with hypertension at high risk of cardiovascular disease, a program that consisted of patients measuring their blood pressure and adjusting their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared to patients who received usual care, according to a study in the August 27 issue of JAMA.
Data from national and international surveys suggest that despite improvements over the last decade, significant proportions of patients have poor control of their elevated blood pressure. Self-monitoring of blood pressure ...
Collaborative care intervention improves depression among teens
2014-08-26
Among adolescents with depression seen in primary care, a collaborative care intervention that included patient and parent engagement and education resulted in greater improvement in depressive symptoms at 12 months than usual care, according to a study in the August 27 issue of JAMA.
Depressed youth are at greater risk of suicide, substance abuse, early pregnancy, low educational attainment, recurrent depression and poor long-term health. Fourteen percent of adolescents between the ages of 13-18 years have major depression yet few receive evidence-based treatments for ...
EPO may help reduce risk of brain abnormalities in preterm infants
2014-08-26
High-dose erythropoietin (EPO; a hormone) administered within 42 hours of birth to preterm infants was associated with a reduced risk of brain injury, as indicated by magnetic resonance imaging, according to a study in the August 27 issue of JAMA.
Survival of premature infants has improved over the past decades, but at the expense of an increase in the number of infants affected by long-term developmental disabilities. Premature infants are at risk of developing encephalopathy of prematurity, which includes structural changes of brain white and gray matter and is associated ...
Study questions generalizability of findings of CV trials for heart attack patients
2014-08-26
An analysis of a cardiovascular registry finds that of clinical trials that included heart attack patients, participation among eligible patients was infrequent and has been declining, and trial participants had a lower risk profile and a more favorable prognosis compared with the broader population of patients who have had a heart attack, according to a study in the August 27 issue of JAMA.
Jacob A. Udell, M.D., M.P.H., of the University of Toronto, and colleagues evaluated whether participants in cardiovascular trials are representative of contemporary patients with ...